PartnershipOct 1, 2026, 07:01 AM
Cardinal Health Extends CVS Health Distribution Deal to 2032
AI Summary
Cardinal Health, Inc. announced it has entered into a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 30, 2032. This extension signifies the continuation of Cardinal Health's current distribution services for CVS Health. In conjunction with this announcement, the company reaffirmed its previously issued fiscal year 2027 non-GAAP earnings per share (EPS) guidance range of $12.40 to $12.60 and its long-term non-GAAP EPS growth range guidance of 12% to 14%.
Key Highlights
- Cardinal Health entered a binding letter of intent to extend pharmaceutical distribution agreements with CVS Health through June 2032.
- The extended agreement reflects the continuation of Cardinal Health's current scope of distribution services.
- Cardinal Health reaffirmed its fiscal year 2027 non-GAAP EPS guidance range of $12.40 to $12.60.
- The company also reaffirmed its long-term non-GAAP EPS growth range guidance of 12% to 14%.
Price Impact
More from CAH